Provenance du réseau au premier degré de Mi Sun
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Qingdao Raisecare Biotechnology Co., Ltd.
 Qingdao Raisecare Biotechnology Co., Ltd. Medical SpecialtiesHealth Technology Qingdao Raisecare Biotechnology Co., Ltd. is a pharmaceutical company founded in 2016. The private company is based in Qingdao, China and develops and promotes pharmaceutical chemicals and products.
5
| Holding Company | Medical Specialties | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mi Sun via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Hongshan
 Hongshan Investment ManagersFinance Hongshan (Hongshan) is a venture and private equity is a subsidiary of SEQUOIA CAPITAL OPERATIONS LLC founded in 2005. The firm headquartered in Hong Kong. | Investment Managers | Private Equity Investor | |
| TRANSCENTA HOLDING LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| QINGDAO BAHEAL MEDICAL INC. | Pharmaceuticals: Major | Director/Board Member | |
| Tsinghua University | College/University | Masters Business Admin | |
| Zhejiang University | College/University | Undergraduate Degree | |
| BEIJING KONRUNS PHARMACEUTICAL CO.,LTD. | Drugstore Chains | Director/Board Member | |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | Miscellaneous Commercial Services | Director/Board Member | |
| INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. | Biotechnology | Director/Board Member | |
| CHENGDU BRIGHT EYE HOSPITAL CO., LTD. | Hospital/Nursing Management | Director/Board Member |
Statistiques
Internationale
| Chine | 8 |
| Îles Cayman | 3 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
| Retail Trade | 2 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 11 |
| Masters Business Admin | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Xiao Bo Lu | 10 |
| Rui Luo | 1 |
| Xi Bin Wen | 1 |
| Li Yong Wang | 1 |
| Shu Jian Zhang | 1 |
